Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal–regulated kinase inhibitors and rapamycin
Patrick Frost(University of California, Los Angeles), Alan Lichtenstein(University of California, Los Angeles)
Cited by 30
Related Papers
AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression
|Journal of Biological Chemistry|2004|329